These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16708988)

  • 1. [Postconditioning: lethal reperfusion injury as a therapeutic target].
    Ovize M
    Ann Cardiol Angeiol (Paris); 2006 Apr; 55(2):66-9. PubMed ID: 16708988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postconditioning in man.
    Thibault H; Piot C; Ovize M
    Heart Fail Rev; 2007 Dec; 12(3-4):245-8. PubMed ID: 17522975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
    Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
    Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postconditioning inhibits mitochondrial permeability transition.
    Argaud L; Gateau-Roesch O; Raisky O; Loufouat J; Robert D; Ovize M
    Circulation; 2005 Jan; 111(2):194-7. PubMed ID: 15642769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postconditioning: from the bench to bedside.
    Cour M; Gomez L; Mewton N; Ovize M; Argaud L
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):117-30. PubMed ID: 20938041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.
    Hausenloy DJ; Tsang A; Yellon DM
    Trends Cardiovasc Med; 2005 Feb; 15(2):69-75. PubMed ID: 15885573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial permeability transition pore and postconditioning.
    Gateau-Roesch O; Argaud L; Ovize M
    Cardiovasc Res; 2006 May; 70(2):264-73. PubMed ID: 16581044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection in reperfusion with postconditioning.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb ischemic postconditioning protects myocardium from ischemia-reperfusion injury.
    Li CM; Zhang XH; Ma XJ; Luo M
    Scand Cardiovasc J; 2006 Oct; 40(5):312-7. PubMed ID: 17012143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention.
    Yang XC; Liu Y; Wang LF; Cui L; Wang T; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Liu SH; Zhang L; Jia HM; Vinten-Johansen J; Zhao ZQ
    J Invasive Cardiol; 2007 Oct; 19(10):424-30. PubMed ID: 17906344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
    Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2004 Feb; 61(3):448-60. PubMed ID: 14962476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postconditioning prevents reperfusion injury by activating delta-opioid receptors.
    Jang Y; Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
    Anesthesiology; 2008 Feb; 108(2):243-50. PubMed ID: 18212569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.